NICE recommends a new MS treatment option for highly active multiple sclerosis

Pharma
NICE recommends natalizumab, including a lower-cost biosimilar, as a new treatment for adults with highly active relapsing-remitting multiple sclerosis, expanding options for thousands of patients.

Latest Publication

Advertisements



Latest Academic Articles

The latest academic articles from a wide range of themes such as energy, environment, health, agriculture, social sciences and technology plus more.

Visit Article Archive

Open Access eBooks

The latest open access and free to distribute eBooks from key industry stakeholders covering health, energy, environment, plus more.

Visit eBook Library

Horizon Europe

COP Climate Change

Special Reports

Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd